Notice: Use of undefined constant E_WARNINGS - assumed 'E_WARNINGS' in /var/www/vhosts/j-ext.net/wp/index.php on line 19
Notice: Use of undefined constant E_WARNINGS - assumed 'E_WARNINGS' in /var/www/vhosts/j-ext.net/wp/wp-content/plugins/wp-o-matic/wpomatic.php on line 17
Notice: Use of undefined constant E_WARNINGS - assumed 'E_WARNINGS' in /var/www/vhosts/j-ext.net/wp/wp-content/plugins/wp-o-matic/inc/tools.class.php on line 4
Using a bio-mimicking analog of one of nature’s most efficient light-harvesting structures, blades of grass, an international research team has taken a major step in developing long-sought polymer architecture to boost power-conversion efficiency of light to electricity for use in electronic devices.
The decision was made based on two phase 3 clinical trials. These trials included 862 patients and compared Eylea 2 mg given every month, given every two months after five initial monthly injection, and macular laser photocoagulation. In both trials, Eylea demonstrated a significant improvement in diabetic retinopathy in patients with DME after two years […]
Dulaglutide is a member of the glucagon-like peptide (GLP-1) receptor agonist class, along with liraglutide, exenatide, and albiglutide. The US Food and Drug Administration (FDA) has approved dulaglutide (Trulicity) as a once a week injection for the treatment of adults with type 2 diabetes.